Shares of Medtronic (MDT) gained 1.4% after the company received approval from the U.S. Food and Drug Administration for Vanta, a recharge-free implantable neurostimulator.
The neurostimulator offers personalized pain relief, broad MRI compatibility, and…
Medtronic Receives FDA Approval for Neurostimulator; Shares Rise 1.4%
Share this article
More News
From Free Trading to the ‘Everything App’
May 19, 2026
The Small-Cap SpaceX Alternative Reddit Is Buying
May 19, 2026
